Of the three biomarkers studied, IL-6 emerges as the most closely related to clinical severity, stroke severity, infarct volume and clinical outcome in stroke patients, although Glu also correlated with stroke severity (but not with outcome) and TNF-alpha levels with infarct volume and outcome. Here, IL6 is linked to Stroke.